Proposes to discontinue covering claims for dual eligible beneficiaries when prescribed barbiturates for the treatment of epilepsy, cancer or a chronic mental health disorder and benzodiazepines for all indications.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media
File 3 - Attachment Media
File 4 - Form CMS-179 Media